Free Trial
NASDAQ:ITOC

Itonic Q2 2026 Earnings Results & Report

$4.07 +0.05 (+1.24%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$4.07 0.00 (-0.12%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Itonic reported Q2 2026 earnings on September 30, 2026. The company reported EPS of -$0.7520, while revenue was $0.05 million.

Earnings Announcement Details

Quarter
Q2 2026
Time
After Market Closes

Itonic EPS Results

Actual EPS
-$0.7520
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Itonic Revenue Results

Actual Revenue
$0.05 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Itonic Q2 2026 Earnings FAQ

Itonic (NASDAQ:ITOC) reported earnings of -$0.7520 per share for Q2 2026. The report was announced on Wednesday, September 30, 2026.

Itonic reported revenue of $0.05 million for Q2 2026.

Itonic Earnings Headlines

Pheton (NASDAQ:PTHL) Stock Price Up 1.3% - What's Next?
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
Itonic (NASDAQ:ITOC) Issues Quarterly Earnings Results
See More Itonic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Itonic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Itonic and other key companies, straight to your email.

About Itonic

Itonic (NASDAQ:ITOC), a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

View Itonic Profile